Abstract

Background: Traumatic brain injury (TBI)-associated coagulopathy is a widely recognized risk factor for secondary brain damage and contributes to poor clinical outcomes. Various theories, including disseminated intravascular coagulation (DIC), have been proposed regarding its pathomechanisms; no consensus has been reached thus far. This study aimed to elucidate the pathophysiology of TBI-induced coagulopathy by comparing coagulofibrinolytic changes in isolated TBI (iTBI) to those in non-TBI, to determine the associated factors, and identify the clinical significance of DIC diagnosis in patients with iTBI.Methods: This secondary multicenter, prospective study assessed patients with severe trauma. iTBI was defined as Abbreviated Injury Scale (AIS) scores ≥4 in the head and neck, and ≤2 in other body parts. Non-TBI was defined as AIS scores ≥4 in single body parts other than the head and neck, and the absence of AIS scores ≥3 in any other trauma-affected parts. Specific biomarkers for thrombin and plasmin generation, anticoagulation, and fibrinolysis inhibition were measured at the presentation to the emergency department (0 h) and 3 h after arrival.Results: We analyzed 34 iTBI and 40 non-TBI patients. Baseline characteristics, transfusion requirements and in-hospital mortality did not significantly differ between groups. The changes in coagulation/fibrinolysis-related biomarkers were similar. Lactate levels in the iTBI group positively correlated with DIC scores (rho = −0.441, p = 0.017), but not with blood pressure (rho = −0.098, p = 0.614). Multiple logistic regression analyses revealed that the injury severity score was an independent predictor of DIC development in patients with iTBI (odds ratio = 1.237, p = 0.018). Patients with iTBI were further subdivided into two groups: DIC (n = 15) and non-DIC (n = 19) groups. Marked thrombin and plasmin generation were observed in all patients with iTBI, especially those with DIC. Patients with iTBI and DIC had higher requirements for massive transfusion and emergency surgery, and higher in-hospital mortality than those without DIC. Furthermore, DIC development significantly correlated with poor hospital survival; DIC scores at 0 h were predictive of in-hospital mortality.Conclusions: Coagulofibrinolytic changes in iTBI and non-TBI patients were identical, and consistent with the pathophysiology of DIC. DIC diagnosis in the early phase of TBI is key in predicting the outcomes of severe TBI.

Highlights

  • Traumatic brain injury (TBI) is one of the leading causes of death and disability, with more than 10 million people hospitalized for TBI every year [1]

  • The results of the present study indicated no correlation between lactate levels and systolic blood pressure (Figure 3B) in isolated TBI (iTBI) patients, but the positive correlation between lactate levels and disseminated intravascular coagulation (DIC) score (Figure 3D) in those patients implies that the increase in lactate levels in TBI patients is caused by DIC-mediated secondary tissue hypoperfusion rather than by hypotension due to hemorrhagic shock

  • The results demonstrated that Injury Severity Score (ISS) was an independent predictor of pathological coagulofibrinolytic changes, namely DIC, in iTBI patients (Table 2), which supports the concept that trauma-induced coagulopathy (TIC) is caused by trauma itself, with or without shock [23]

Read more

Summary

Introduction

Traumatic brain injury (TBI) is one of the leading causes of death and disability, with more than 10 million people hospitalized for TBI every year [1]. TBI-associated coagulopathy is widely recognized as a risk factor for secondary brain damage and contributes to poor clinical outcomes. TBI-associated coagulopathy contributes to poor outcomes in both hypocoagulability, leading to the expansion of intracranial hemorrhage, and hypercoagulability, leading to secondary cerebral ischemia due to intravascular thrombosis in the injured brain [4,5,6,7,8]. Elucidation of the pathophysiology of TBI-induced coagulopathy may contribute to improving the outcomes of TBI patients, but no consensus has been reached far. Traumatic brain injury (TBI)-associated coagulopathy is a widely recognized risk factor for secondary brain damage and contributes to poor clinical outcomes. This study aimed to elucidate the pathophysiology of TBI-induced coagulopathy by comparing coagulofibrinolytic changes in isolated TBI (iTBI) to those in non-TBI, to determine the associated factors, and identify the clinical significance of DIC diagnosis in patients with iTBI

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.